The FASEB Journal, Vol 7, 1359-1366, Copyright © 1993 by The Federation of American Societies for Experimental Biology

REVIEWS

Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration

M Simionescu and N Simionescu
Institute of Cellular Biology and Pathology, Bucharest, Romania.

The inception of experimentally induced atherogenesis is marked by subtle biochemical and ultrastructural changes of the arterial intima, modifications that precede the monocytes migration within the vessel wall. Long before any recognizable endothelial denudation, hypercholesterolemia induces a sequence of prelesional events that start with the enhanced transport of excess plasma lipoproteins especially by transcytosis, followed by intima accumulation of chemically (oxidatively) modified and reassembled lipoproteins (MRLp). Exposure of endothelial cells concomitantly to hypercholesterolemia on the luminal side, and to the MRLp cytotoxic effects on the abluminal side, generates endothelial dysfunctions with altered biosynthetic activities. The latter are manifested initially by the hyperplasia of basal lamina and its disjunction from endothelium, and by the proliferation and reorganization of a modified extracellular matrix that traps MRLp. The cytotoxic effects of MRLp contribute to the endothelial production of chemoattractants and adhesion molecules that are instrumental in monocyte recruitment and migration in the subendothelium, where activated and differentiated as macrophages, they avidly ingest MRLp and their complexes to form foam cells. The latter are the hallmark of fatty streaks that marks the transition from the prelesional to the lesional stage of atherogenesis. Understanding the earliest biochemical alterations of the artery wall is a prerequisite for designing more successful means of prevention and treatment of atherosclerosis.

This article has been cited by other articles:

				R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]

				R. O. Dull and J. G.N. Garcia Leukocyte-Induced Microvascular Permeability: How Contractile Tweaks Lead to Leaks Circ. Res., June 14, 2002; 90(11): 1143 - 1144. [Full Text] [PDF]

				P. G. Frank, F. Galbiati, D. Volonte, B. Razani, D. E. Cohen, Y. L. Marcel, and M. P. Lisanti Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1204 - C1214. [Abstract] [Full Text] [PDF]

				B. Hennig, M. Toborek, and C. J. McClain High-Energy Diets, Fatty Acids and Endothelial Cell Function: Implications for Atherosclerosis J. Am. Coll. Nutr., April 1, 2001; 20(2): 97 - 105. [Abstract] [Full Text] [PDF]

				S.-i. Suga, H. Itoh, Y. Komatsu, H. Ishida, T. Igaki, J. Yamashita, K. Doi, T.-H. Chun, T. Yoshimasa, I. Tanaka, et al. Regulation of Endothelial Production of C-Type Natriuretic Peptide by Interaction between Endothelial Cells and Macrophages Endocrinology, April 1, 1998; 139(4): 1920 - 1926. [Abstract] [Full Text] [PDF]

				H. Kato, J. Hou, A. V. Chobanian, and P. Brecher Effects of Angiotensin II Infusion and Inhibition of Nitric Oxide Synthase on the Rat Aorta Hypertension, August 1, 1996; 28(2): 153 - 158. [Abstract] [Full Text]

				J. R. Gamble, S. Bradley, L. Noack, and M. A. Vadas TGF-ß and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 949 - 955. [Abstract] [Full Text]

				M. Noris, M. Morigi, R. Donadelli, S. Aiello, M. Foppolo, M. Todeschini, S. Orisio, G. Remuzzi, and A. Remuzzi Nitric Oxide Synthesis by Cultured Endothelial Cells Is Modulated by Flow Conditions Circ. Res., April 1, 1995; 76(4): 536 - 543. [Abstract] [Full Text]